Ezetimibe Impurity 72 | CAS 1501-05-9 - Request Quote
Ezetimibe Impurity 72
| SZ CAT No: | SZ-E026146 |
| CAS No | 1501-05-9 |
| Mol.F. | C11H12O3 |
| Mol.Wt. | 192.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ezetimibe Impurity 72 is chemically 5-Oxo-5-phenylpentanoic acid. Ezetimibe Impurity 72 is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe Impurity 72 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ezetimibe.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1501-05-9
Purchase 1501-05-9
Order 1501-05-9
Enquire 1501-05-9
price of 1501-05-9
1501-05-9 Supplier
1501-05-9 Manufacturer
1501-05-9 Exporter
buy high quality Ezetimibe Impurity 72
Purchase Ezetimibe Impurity 72
Ezetimibe Impurity 72 suppliers
Ezetimibe Impurity 72 manufacturers
Ezetimibe Impurity 72 price
Order Ezetimibe Impurity 72
Enquire Ezetimibe Impurity 72
Ezetimibe Impurity 72 cost
Ezetimibe Impurity 72 Supplier
Ezetimibe Impurity 72 Distributor
Ezetimibe Impurity 72 for Method Validation
Ezetimibe Reference Standard
Ezetimibe Impurity 72 for ANDA Filing
Ezetimibe Impurity 72 for Forced Degradation Studies
Ezetimibe Impurity 72 Identification Standards
Ezetimibe Impurity 72 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


